Zabol, Iran during (December) 2017-2018. Presumptive identification was performed by conventional biochemical tests including lactose fermentation, Gram stain, catalase, and oxidase. Furthermore, K. pneumoniae speciesspecific polymerase chain reaction (PCR) was performed by primers amplifying internal transcribed spacer region based on previously described conditions. 6, 7 Antimicrobial Susceptibility Testing Antibiotic resistance was assessed using ertapenem (10 µg), meropenem (10 µg), gentamicin (10 µg), ciprofloxacin (5 µg), cefepime (30 µg), amikacin (30 µg), cefoxitin (30 µg), and ceftriaxone (30 µg) antibiotics which were purchased from the MSAT Company (Merseyside, UK). Then, the resistance was ascertained by Kirby-Bauer's disk diffusion method and Clinical and Laboratory Standards Institute guidelines. 8 Further, the minimum inhibitory concentration of imipenem (Sigma-Aldrich, USA, within the range of 64-0.5 µg/mL) was determined using microdilution method. 8 Moreover, Pseudomonas aeruginosa ATCC 27853 was used as quality control. Finally, imipenem-resistant isolates were subjected to phenotypical detection of MBL enzymes by imipenem-EDTA combined disk test as described earlier 9 and the known clinical isolate of MBL-producing P. aeruginosa was utilized as quality control.
PCR

DNA Extraction
The boiling method was employed for DNA extraction. 10 Briefly, 2 fresh colonies of K. pneumoniae were completely dissolved in 400 µL sterile distilled water. Then, the obtained suspension was heated at 100ºC for 10 minutes. Eventually, the suspension was centrifuged at 13 000 g for 10 minutes in order to separate DNA and the supernatant was used for the target amplification.
PCR Method
PCR amplification was performed using specific primers (Table 1 ) in order to detect blaAIM, blaVIM, blaNDM-1, and blaSPM genes.
11 Ampliqon (Ampliqon, Danish) ready to use master mix was employed for PCR amplification based on the condition described earlier. 11 Finally, the separated PCR products were visualized by staining with Sybr safe (Thermo Fisher Scientific Inc., USA).
Results
Seventy isolates of K. pneumoniae were collected from sputum (5 cases, 7.1%), urine (58 cases, 83%), blood (3 cases, 4.2%), and wound (4 cases, 5.7%). Among these, 40 (57.1%) isolates belonged to males and 30 (42.9%) of them were related to females. The results of K. pneumoniae species-specific PCR are illustrated in Figure 1 . As shown, the isolates are mostly susceptible to ertapenem (n = 68, 97.1%), imipenem (n = 67, 95.7%), meropenem (n = 67, 95.7%), followed by gentamicin (n = 65, 92.8%), amikacin (n = 65, 92.8%), cefepime (n = 60, 85.7%), ciprofloxacin (n = 58, 82.8%), cefoxitin (n = 57, 81.4%), and ceftriaxone (n = 57, 81.4%) antibiotics. Totally, 3 (4.3%) isolates were imipenem-resistant with a MIC of 16 µg/mL. Additionally, all imipenem-resistant isolates were MBL positive by imipenem-EDTA combined disk test. Based on the results of PCR displayed in Figure 2 , two isolates were blaNDM positive while other resistant genes were not detected.
Discussion
The current study investigated the antibiotic resistance profile of 70 K. pneumoniae isolated from clinical specimens of patients who referred to Amiralmomenin hospital of Zabol as the only referral hospital in the region. The findings revealed that the majority of isolates (80%) were susceptible to the tested antibiotics, namely, cefepime, carbapenems, ciprofloxacin, gentamicin, cefoxitin, amikacin, and ceftriaxone.
Different antibiotics such as aminoglycosides and betalactamases are commonly used to treat the infection caused by K. pneumoniae while the prevalence of antibiotic resistance has rapidly increased in recent years threatening global public health, especially in developing countries. 12, 13 In fact, treating drug-resistant infections has become more challenging owing to the evolution of several antibiotic-resistance mechanisms resulted from widespread use and misuse of antibiotics. 12, 13 In addition, based on the results of the present study, the isolates were mainly found to be susceptible to ertapenem, imipenem, meropenem, gentamicin, and amikacin. Overall, 3 isolates were imipenem-resistant. Further, the prevalence of antimicrobial resistance isolates varied between and within different countries. For instance, Fallah et al, in their study which was conducted in Tehran, reported that 59%, 36%, and 55.5% of the investigated K. pneumoniae isolates were resistant against ceftriaxone, cefepime, and ciprofloxacin, respectively. 13 In addition, the findings of a comprehensive meta-analysis showed that the resistance rate of K. pneumoniae against different antibiotics in different provinces of Iran was at an alarming level.
14 For example, based on a report, resistance to amikacin ranged from 6.1% in Qom province to 47% in Isfahan province. Furthermore, resistance to ciprofloxacin and gentamicin in different provinces of Iran differed greatly, ranging from 12% to 53% and 6% to 59%, respectively. 14 Internationally, resistance to different classes of antibiotics such as beta-lactam and aminoglycoside in the majority of European countries such as Denmark, Finland, Sweden, Germany, and Norway are much lower compared to Iran. 14 These differences may be attributed to the low quality of personal hygiene, the indiscriminate use of antibiotics, infection control policies, and the presence of some risk factors such as previous hospitalization and long-term staying at ICU. 14, 15 Since carbapenems are relatively resistant to hydrolysis by most β-lactamases, they are currently used to treat serious infections caused by multi-drug resistance bacteria, showing resistance against cephalosporins, penicillins, and β-lactam/β-lactamase inhibitor combinations. 16 CR isolates of K. pneumoniae are known to be associated with high mortality and morbidity rates due to limited available therapeutic alternatives, indicating the importance of detection strategies. [14] [15] [16] [17] [18] Based on the results of the current study, 3 (4.3%) K. pneumoniae isolates were CRKP among which two of them were blaNDM positive. Moreover, a comprehensive meta-analysis conducted to estimate the prevalence of CRKP in different provinces of Iran indicated that 11% of the isolated K. pneumoniae were CR, ranging from 0.004 in Tehran to 58% in Isfahan provinces.
14 Conversely, the reported prevalence of CRKP in Romania and Greece with respective frequencies of 24% and 61% were much higher than that of Iran, which contradicts the results of the present study. 15 On the other hand, no CRKP isolates were detected in reports from Sweden, Finland, Estonia, and Iceland. 15 These contradictory results may be related to the low quality of personal hygiene, [14] [15] [16] [17] [18] variable sample sizes, the indiscriminate use of antibiotics, poor infection control policies, and the presence of some risk factors like previous hospitalization and long-term staying at ICU. [14] [15] [16] [17] [18] The results of the current study further revealed that 4.3% of isolates were MBL enzymes positive using imipenem-EDTA combined disk test. Among them, two isolates were blaNDM positive while the other investigated resistance genes were not detected. Several independent studies reported blaNDM-harboring K. pneumoniae from different provinces of Iran. 18, 19 The mechanisms of resistance to carbapenems are multi-factorial including the overexpression of efflux pumps, the production of extended spectrum betalactamases (ESBL), and mutations in porins or Penicillinbinding Proteins. Producing ESBL is regarded as the most important mechanism employed by the bacteria to destroy the structure of beta-lactam antibiotics. Based on their structural properties, ESBLs are classified into A, B, C, and D groups. Class B beta-lactamases (i.e., blaVIM, blaIMP, blaNDM, and blaSPM), which include MBLs, are among the most essential mechanisms. [14] [15] [16] [17] [18] [19] The findings of different independent studies demonstrated that plasmid-expressed blaNDM-1 gene encoding the NDM-1 metallo-β-lactamase is spreading worldwide. For example, different outbreaks of blaNDM producing isolates are reported from patients referring to hospitals in India, Pakistan, Bangladesh, Poland, the US, Canada, and Spain. 20 Rapid and accurate detection of MBL genes is of paramount importance since these genes are normally located at transposable genetic elements such as plasmids and transposons facilitating the spread of resistance genes between different isolates. In addition, these resistance genes are accompanied by other resistance genes such as beta-lactam hydrolyzing enzymes, aminoglycoside modifying enzymes, and 16SrRNA methylase genes (i.e., armA, rmtA, rmtB, and rmtC), conferring resistance to all β-lactams and aminoglycosides. [18] [19] [20] 
Conclusion
In general, the incidence of CRKP was not at a high level in Zabol region. Accordingly, the detection of blaNDMproducing K. pneumoniae highlights the necessity of continued monitoring of antibiotic resistance profile in the hospitals. More importantly, failure in accurate and timely detection of MBL genes may result in the emergence of multi-drug resistant bacteria.
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